Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint ArthroplastyChristopher Wanderling, Jawed Fareed, Debra Hoppensteadt et al.|Clinical and Applied Thrombosis/Hemostasis|2017Cited by 19
Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty PatientsAndrew Burleson, William Hopkinson, Nil Güler et al.|Clinical and Applied Thrombosis/Hemostasis|2015Cited by 13
Levels of Matrix-Degrading Enzymes and Lubricin in Patients With Degenerative Joint Disease Requiring ArthroplastyChristopher Wanderling, William Hopkinson, Jawed Fareed et al.|Clinical and Applied Thrombosis/Hemostasis|2017Cited by 9